CareSignal Raises Undisclosed Funding


CareSignal (fka Epharmix), a St. Louis-based an accessible remote patient monitoring platform provider, raised an undisclosed funding round.

Backers included OSF Ventures, UnityPoint Health Ventures, Nueterra Capital and 1984 Ventures.

The company intends to use the funds to grow sales and marketing efforts and to expand nationally to new payer and large provider partners.

Led by Blake Marggraff, CEO and co-founder, CareSignal provides an accessible remote patient monitoring platform that improves payer and provider performance in value-based care by engaging and identifying rising-risk patients. Care teams receive real-time alerts enabling real-time prioritization and outreach, and patients respond to evidence-based questions via text messages or phone calls.



Join the discussion